Davis's Drug Guide : Food and Drug Administration Press Releases

Food and Drug Administration Press Releases
FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid
FDA Approves New Drug to Treat Severe Form of Epilepsy
FDA Warns Public of Extortion Scam by FDA Impersonators
FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer
FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes
FDA Approves Toviaz, a New Drug to Treat Overactive Bladder
HHS FDA Grants Tentative Approval for 75th Generic Anti-Retroviral Drug as Part of President's Emergency Plan for AIDS Relief
FDA Statement on Release of Bisphenol A (BPA) Subcommittee Report
FDA Issues Warning Letters to Bayer HealthCare for Illegally Marketing Two Unapproved Drugs
FDA Approves Lung Valve to Control Some Air Leaks after Surgery
FDA Approves Updated Labeling for Psoriasis Drug Raptiva
FDA Creates Web Page with Drug Safety Information for Patients, Health Care Professionals
FDA Licenses for Marketing New Therapy for Rare Genetic Disease
FDA Approves Rapaflo for the Treatment of Symptoms Due to an Enlarged Prostate Gland
FDA Launches Food Defense Awareness Training Kit for Employees in the Food Industry
FDA Licenses Drug to Prevent Joint Damage in Children with Hemophilia A
FDA Statement Following CHPA's Announcement on Nonprescription Over-the-Counter Cough and Cold Medicines in Children
FDA Approves Use of Temporary Pump to Assist Heart's Right Side
FDA and PATH Malaria Vaccine Initiative Announce Research Collaboration
FDA Detects Melamine Contamination in Flavored Drink
FDA Issues Interim Safety and Risk Assessment of Melamine and Melamine-related Compounds in Food
FDA Awards $5.2 Million in Grants to Further Food and Feed Safety
FDA Awards up to $2.5 Billion to Modernize Information Technology over Ten Years
FDA Analysis Shows Cholesterol Lowering Medications Do Not Increase the Risk of Lou Gehrig's Disease
FDA Updates Health Information Advisory on Melamine Contamination
FDA Warns Companies to Stop Marketing Unapproved Ophthalmic Balanced Salt Solution Drug Products and Topical Drug Products Containing Papain
FDA Proposes Label Requirements for Refused Imported Foods
FDA Issues Draft Guidance on Regulating Genetically Engineered Animals
FDA Issues Warning Letters to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy Plants in India
FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers
FDA Approves Treatment for Rare Neurologic Disease

Food and Drug Administration Press Releases

FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid

Description

The U.S. Food and Drug Administration today issued an expedited approval of a supplemental application that allows for changes in the manufacturing of Sucraid (sacrosidase) Oral Solution.
Web Link

Food and Drug Administration Press Releases is a sample topic found in FDA Drug News. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other FDA Drug News topics, please login or purchase a subscription.

Top

Food and Drug Administration Press Releases

Next >>

Content Manager: Search Unbound MEDLINE; Display all Sections; Font Size; Print Section Topic